Re: Abiraterone and Olaparib for Metastatic Castration-resistant Prostate Cancer. Giesen A, Devlies W, Claessens F, Joniau S, et al. Eur Urol 2023 Nov 27:S0302-2838(23)03273-6. doi: 10.1016/j.eururo.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Giesen A, Devlies W, Claessens F, Joniau S, et al. Re: Abiraterone and Olaparib for Metastatic Castration-resistant Prostate Cancer. Eur Urol 2023 Nov 27:S0302-2838(23)03273-6. doi: 10.1016/j.eururo.2023.
PMID: 38016839